SCHEMBL21348178

SCHEMBL21348178

CC(=O)N(C)CCN(C)C(=O)OCc1ccc(C(C)C)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ LMNA P02545 1/20 0.47
▸ RXRA P19793 1/20 0.43
▸ RXRB P28702 1/20 0.43
▸ IDO1 P14902 2/20 0.42
▸ PRSS1 P07477 1/20 0.41
▸ TPSAB1 Q15661 1/20 0.41
▸ NPC1 O15118 4/20 0.40
▸ RAB9A P51151 4/20 0.40
▸ KDM4E B2RXH2 2/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ EGFR P00533 1/20 0.39
▸ POLB P06746 1/20 0.37
▸ NPBWR1 P48145 1/20 0.37
▸ MCHR1 Q99705 1/20 0.37
▸ F13A1 P00488 1/20 0.37
▸ TGM2 P21980 1/20 0.37
▸ TGM1 P22735 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25978782 0.90 MEN1 (0.48) MEN1KMT2ALMNARXRARXRB
SCHEMBL25749525 0.89 MEN1 (0.46) MEN1KMT2ALMNARXRARXRB
SCHEMBL24062709 0.88 NPC1 (0.41) MEN1KMT2ALMNAPRSS1TPSAB1
SCHEMBL23489098 0.87 MEN1 (0.49) MEN1KMT2ALMNARXRARXRB
SCHEMBL25749532 0.86 LMNA (0.46) MEN1KMT2ALMNARXRARXRB
SCHEMBL25751042 0.85 MEN1 (0.45) MEN1KMT2ALMNARXRARXRB
SCHEMBL25749404 0.85 MEN1 (0.45) MEN1KMT2ALMNARXRARXRB
SCHEMBL21348174 0.84 MEN1 (0.50) MEN1KMT2ALMNARXRARXRB
SCHEMBL21348175 0.84 PRSS1 (0.44) PRSS1TPSAB1NPC1RAB9AF13A1
SCHEMBL26502414 0.82 MEN1 (0.49) MEN1KMT2ALMNARXRARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024141575-A1 ANTIBODY-DRUG CONJUGATES TARGETING UPARAP COMPRISING EXATECAN DERIVATIVES ADCENDO APS (DK) 2024-07-04 — — WO disclosed
EP-4223318-A1 ANTITUMOR COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF Duality Biologics (Suzhou) Co., Ltd. (CN) 2023-08-09 — — EP disclosed
EP-4011396-A1 RELEASABLE CONJUGATES QuiaPEG Pharmaceuticals AB (SE) 2022-06-15 — — EP disclosed
WO-2020053815-A1 RELEASABLE GLP-1 CONJUGATES QUIAPEG PHARMACEUTICALS AB (SE) 2020-03-19 — — WO disclosed
WO-2019171358-A1 RELEASABLE ANTIBODY CONJUGATES QUIAPEG PHARMACEUTICALS AB (SE) 2019-09-12 — — WO disclosed
Send feedback